What is Cometriq (Cabozantinib)
Cometriq is a prescription medicine used to treat people with medullary thyroid cancer that has spread to other parts of the body (metastatic)
Drug Manufacturer / Marketeer :
M/s Exelixis Inc
20 mg or 80 mg cabozantinib.
Cometriq is indicated for treatment of progressive, metastatic medullary thyroid cancer. It is a Tyrosine Kinase Inhibitor.
For treatment related information, please consult your treating Physician.
Cometriq capsules are supplied as printed hard gelatin capsules containing cabozantinib (S) – malate equivalent to 20 mg or 80 mg cabozantinib.
Storage and handling:
Store at 20°- 25° C, excursions permitted to 15° to 30° C.
How do we source the Drug?
SMIQ Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.
Company that Manufactures/ Markets:
M/s Exelixis Inc.
Assistance Cell in India:
For ONCOLOGY DRUG:Cometriq (Cabozantinib) Capsules 20MG or 80MG price.
Contact us @ +91 7678048225 or by email firstname.lastname@example.org.